top of page
1.jpg

In November 2013, the ARPharM General Assembly adopted its Code of Disclosure of the Provision of Value by Pharmaceutical Companies to Healthcare Professionals and Healthcare Organizations, applying the principles of the EFPIA Code "Transparency of Relationships with Healthcare Professionals".

Disclosure

Transparency creates trust and combats mistrust!

In November 2013, the ARPharM General Assembly adopted a Disclosure Code, implementing the EFPIA Code of Transparency in collaboration with healthcare professionals.

With the new Code, all future payments in kind by the pharmaceutical industry to physicians and further healthcare professionals, along with organisations in the healthcare field, shall be made public.

The comprehensive transparency promotes an even greater strengthening of patient trust in the prescription decisions of the physician

About Disclosure

Collaboration between pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) benefits patients. It is a relationship that has delivered new vaccines and medicines and fosters the innovation that improves patients’ lives. Furthermore, patient organisations (POs) play a critical role in Europe’s healthcare: from prevention and awareness, through research and development, regulatory and HTA decision-making, to service design and outcomes measurement

Bringing greater transparency to this already well-regulated and vital relationship, builds understanding of industry-POs and HCPs/HCOs collaboration and, in the context of increasing societal expectations on transparency, addresses directly public concerns about interactions between the medical community and the pharmaceutical industry.

Advantages

The cooperation between pharmaceutical companies and doctors has proven its worth and is already closely controlled by clear guidelines, regulations, and codes. The transparency creates further confidence in already proven partnerships. Through the Disclosure Code, the contributions from ARPharM companies to doctors, healthcare professionals, and organizations become transparent and therefore also traceable.

Disclaimer of liability

Certain links in this website will lead to websites that are not under the control of ARPharM. When you activate these you will leave the ARPharM website. ARPharM has no control over and accepts no liability in respect of materials, data, products or services available on any website which is not under the control of ARPharM.

bottom of page